85 related articles for article (PubMed ID: 8710050)
21. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
22. Human peripheral blood lymphocyte severe combined immunodeficiency (hu-PBL SCID) models of toxoplasmosis.
Beaman MH; Remington JS; Meyer DJ
Immunol Cell Biol; 2000 Dec; 78(6):608-15. PubMed ID: 11114971
[TBL] [Abstract][Full Text] [Related]
23. [Effects of separate administration of low-dose CDDP on antitumor immune reactivity for treatment of malignant glioma].
Nishihara T; Tanaka S; Murakami M; Hirakawa M; Nagashima T
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1197-202. PubMed ID: 7661572
[TBL] [Abstract][Full Text] [Related]
24. Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
Dejaegher J; Verschuere T; Vercalsteren E; Boon L; Cremer J; Sciot R; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2017 Nov; 141(9):1891-1900. PubMed ID: 28681455
[TBL] [Abstract][Full Text] [Related]
25. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines.
Bullard DE; Schold SC; Bigner SH; Bigner DD
J Neuropathol Exp Neurol; 1981 Jul; 40(4):410-27. PubMed ID: 7252525
[TBL] [Abstract][Full Text] [Related]
26. [Establishment of human retinoblastoma model in human immune reconstruction non-obese diabetic-severe combine immunodeficient mice].
Zhong XF; Ge J; Peng FH; Zhang B; Lin JX; Zhang WX; Li YP
Zhonghua Yan Ke Za Zhi; 2007 Aug; 43(8):739-43. PubMed ID: 18001574
[TBL] [Abstract][Full Text] [Related]
27. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
[TBL] [Abstract][Full Text] [Related]
28. The effect of human IL-2-activated natural killer and T cells on graft-versus-host disease and graft-versus-leukemia in SCID mice bearing human leukemic cells.
Xun CQ; Thompson JS; Jennings CD; Brown SA
Transplantation; 1995 Oct; 60(8):821-7. PubMed ID: 7482742
[TBL] [Abstract][Full Text] [Related]
29. Endothelial progenitor cells' "homing" specificity to brain tumors.
Moore XL; Lu J; Sun L; Zhu CJ; Tan P; Wong MC
Gene Ther; 2004 May; 11(10):811-8. PubMed ID: 15057261
[TBL] [Abstract][Full Text] [Related]
30. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
31. [The immune reconstitution in Scid mice and the effect of T, B, NK cells on the growth potential of CNE-2Z-H5 transplanted tumor].
Hu XR; Shen SJ; Mo MY
Zhonghua Bing Li Xue Za Zhi; 1994 Dec; 23(6):355-7. PubMed ID: 7720115
[TBL] [Abstract][Full Text] [Related]
32. lacZ-neoR transfected glioma cells in syngeneic rats: growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS.
Visted T; Thorsen J; Thorsen F; Read TA; Ulvestad E; Engebraaten O; Sorensen D; Ylä-Herttuala S; Tyynela K; Rucklidge G; Edvardsen K; Bjerkvig R; Lund-Johansen M
Int J Cancer; 2000 Jan; 85(2):228-35. PubMed ID: 10629082
[TBL] [Abstract][Full Text] [Related]
33. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
[TBL] [Abstract][Full Text] [Related]
34. Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer.
Gyory F; Mezosi E; Szakall S; Bajnok L; Varga E; Borbely A; Gazdag A; Juhasz I; Lukacs G; Nagy EV
Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):359-64. PubMed ID: 16025395
[TBL] [Abstract][Full Text] [Related]
35. Development of a xenograft glioma model in mouse brain.
Kaye AH; Morstyn G; Gardner I; Pyke K
Cancer Res; 1986 Mar; 46(3):1367-73. PubMed ID: 3943101
[TBL] [Abstract][Full Text] [Related]
36. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.
Tong AW; Huang YW; Zhang BQ; Netto G; Vitetta ES; Stone MJ
Anticancer Res; 1993; 13(3):593-7. PubMed ID: 8391243
[TBL] [Abstract][Full Text] [Related]
37. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
[TBL] [Abstract][Full Text] [Related]
38. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.
Hess SD; Egilmez NK; Shiroko J; Bankert RB
Cancer Gene Ther; 2001 May; 8(5):371-7. PubMed ID: 11477457
[TBL] [Abstract][Full Text] [Related]
39. Rapid growth and spontaneous metastasis of human germinal tumors ectopically transplanted into scid (severe combined immunodeficiency) and scid-nudestreaker mice.
Nomura T; Takahama Y; Hongyo T; Takatera H; Inohara H; Fukushima H; Ono S; Hamaoka T
Jpn J Cancer Res; 1991 Jun; 82(6):701-9. PubMed ID: 1906856
[TBL] [Abstract][Full Text] [Related]
40. Human T-and B-cell functions in SCID-hu mice.
Roncarolo MG; Carballido JM; Rouleau M; Namikawa R; de Vries JE
Semin Immunol; 1996 Aug; 8(4):207-13. PubMed ID: 8883143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
